Calidi Biotherapeutics (CLDI) Current Assets (2021 - 2026)
Calidi Biotherapeutics (CLDI) posted quarterly Current Assets of $6.3 million for Q4 2025, down 38.83% year-over-year from $10.2 million in Q4 2024, and down 43.27% quarter-over-quarter from $11.0 million in Q3 2025.
Calidi Biotherapeutics (CLDI) Current Assets (2021 - 2026) Analysis & Trends
Calidi Biotherapeutics' Current Assets history runs 5 years deep, the most recent figure standing at $6.3 million for Q4 2025.
- In Q4 2025, Current Assets fell 38.83% year-over-year to $6.3 million; the TTM figure through Dec 2025 stood at $6.3 million (down 38.83% YoY), while the FY2025 annual figure was $6.3 million, down 38.83% from the prior year.
- Current Assets for Q4 2025 stood at $6.3 million, down from $11.0 million in the prior quarter.
- The five-year high for Current Assets was $11.7 million in Q3 2023, with the low at $268864.0 in Q1 2023.
- The 5-year median for Current Assets is $1.9 million (2024), against an average of $4.3 million.
- The sharpest annual moves came in 2023 and 2024: Current Assets jumped 2339.4% in 2023, then plunged 81.0% in 2024.
- Calidi Biotherapeutics' Current Assets stood at $1.5 million in 2021, then tumbled by 47.02% to $786000.0 in 2022, then soared by 447.46% to $4.3 million in 2023, then jumped by 137.67% to $10.2 million in 2024, then slumped by 38.83% to $6.3 million in 2025.
- Business Quant data shows CLDI's Current Assets at $6.3 million in Q4 2025, $11.0 million in Q3 2025, and $6.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | Calidi Biotherapeutics | 1.88 Mn | -2.22 Mn | - | 5.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.43 Mn |
| Dec 31, 2025 | 6.26 Mn |
| Sep 30, 2025 | 11.03 Mn |
| Jun 30, 2025 | 6.05 Mn |
| Mar 31, 2025 | 11.49 Mn |
| Dec 31, 2024 | 10.23 Mn |
| Sep 30, 2024 | 2.22 Mn |
| Jun 30, 2024 | 1.63 Mn |
| Mar 31, 2024 | 1.94 Mn |
| Dec 31, 2023 | 4.30 Mn |
| Sep 30, 2023 | 11.69 Mn |
| Jun 30, 2023 | 795,478.00 |
| Mar 31, 2023 | 268,864.00 |
| Dec 31, 2022 | 786,000.00 |
| Sep 30, 2022 | 479,094.00 |
| Jun 30, 2022 | 759,668.00 |
| Mar 31, 2022 | 1.03 Mn |
| Dec 31, 2021 | 1.48 Mn |